DICLOFENAC News
DICLOFENAC currently has 0 news articles, with 23 predicted indications.
This page combines the AI-predicted indications for DICLOFENAC with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (23):
- ankylosing spondylitis (99.0%)
- melanoacanthoma (99.0%)
- spondyloarthropathy, susceptibility to (99.0%)
- inverted follicular keratosis (99.0%)
- rheumatoid arthritis (99.0%)
- actinic cheilitis (99.0%)
- arthropathy (99.0%)
- skin disease (99.0%)
- keratoacanthoma (99.0%)
- actinic keratosis (disease) (99.0%)
- osteoarthritis susceptibility (99.0%)
- osteoarthritis (99.0%)
- seborrheic keratosis (99.0%)
- hypotrichosis simplex of the scalp (99.7%)
- acromesomelic dysplasia, Hunter-Thompson type (99.7%)
- pseudoachondroplasia (99.7%)
- brachyolmia (99.7%)
- brachyolmia-amelogenesis imperfecta syndrome (99.6%)
- congenital hypotrichosis milia (99.6%)
- myosclerosis (99.6%)
- diffuse alopecia areata (99.6%)
- juvenile idiopathic arthritis (99.2%)
- WHIM syndrome (99.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.